Amgen Says It Didn't Mislead On Biosimilar Marketing Date
Amgen Inc. in a brief unsealed Tuesday urged a Delaware federal judge to dismiss a claim by Genentech Inc. that it had breached a "binding" representation that it would market its...To view the full article, register now.
Already a subscriber? Click here to view full article